The limitations of the existing drug discovery paradigm reveals that there are still no effective prevention or real cur...
AUM Biosciences is a global clinical-stage biotech company, focused on discovering and developing novel target...
Pfizer Inc. has announced an agreement with the US government to supply 10 million treatment courses of its investi...
Pfizer Inc. has announced that it is seeking Emergency Use Authorization (EUA) of its investigational oral antivira...
South Korea-based GI Innovation has inked a biopharmaceutical manufacturing and development based Memorandum o...
Singapore's AUM Biosciences (AUM) has completed of $27 million series A funding round to develop a drug pipeline focused...
CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summi...
US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...
SuperTrans Medical ("STM"), an Australian biopharmaceutical company developing novel antibiotics that target difficult-t...
BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collabo...
French firm POXEL SA along with its partner, Sumitomo Dainippon Pharma, is launching TWYMEEG (Imeglimin hydro...
What unique initiatives are being taken by the company to connect microbiome with human health? Which are the major ther...
US-based Senhwa Biosciences, Inc. has announced that its novel oral drug, Silmitasertib, has been included in Taiwa...
Healx, the AI-powered, UK-founded global drug discovery company, has entered a partnership with Japan's Ono Pharmace...
Otsuka Pharmaceutical Development & Commercialization, Inc., a subsidiary of Japan-based Otsuka Pharmaceutical, has ...
Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...
China-based startups Insilico Medicine and Westlake Pharma have announced a strategic partnership to jointly develop inn...
Currently, estrogen-receptor-positive breast cancer accounts for about 70% of all breast cancers, with hormone therapy (...
